Generic name: MELOXICAM 30mg in 1mL
Dosage form: injection
Medically reviewed by Drugs.com. Last updated on Feb 17, 2020.
Use for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)].
For intravenous administration only.
The recommended dose of ANJESO is 30 mg once daily, administered by intravenous bolus injection over 15 seconds.
When initiating ANJESO, monitor patient analgesic response. Because the median time to meaningful pain relief was 2 and 3 hours after ANJESO administration in two clinical studies, a non-NSAID analgesic with a rapid onset of effect may be needed, for example, upon anesthetic emergence or resolution of local or regional anesthetic blocks [see Clinical Studies (14)].
Some patients may not experience adequate analgesia for the entire 24-hour dosing interval and may require administration of a short-acting, non-NSAID, immediate-release analgesic [see Clinical Studies (14)].
To reduce the risk of renal toxicity, patients must be well hydrated prior to administration of ANJESO.
Visually inspect parenteral drug products for particulate matter and discoloration prior to administration. Should the contents appear discolored or contain particulate matter, discard the vial [see Dosage Forms and Strengths (3)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
- Is meloxicam a narcotic?
- Is meloxicam very similar to Celebrex?
- Is meloxicam a sulfa drug?
- Can I take Meloxicam and Aleve or Tylenol together?
- Can meloxicam cause drowsiness and headache?
- How long do I wait after taking 400 mg ibuprofen to take 15 mg of meloxicam?
- Is meloxicam helpful in gout treatment?
- What is the difference between meloxicam and ibuprofen?
More about Anjeso (meloxicam)
- Side Effects
- During Pregnancy or Breastfeeding
- Drug Interactions
- Drug class: Nonsteroidal anti-inflammatory drugs
- FDA Alerts (4)
- FDA Approval History